Combinative effects of β-elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma
Hemangioma (HA) is one of the most common benign vascular tumors among children. Propranolol is used as the first-line treatment for hemangioma and is a non-selective blocker of the β-adrenergic receptor. β-elemene is a compound extracted from Rhizoma zedoariae and has been approved for the treatmen...
Main Authors: | Zhenyu Wang, Yinxian Chen, Lin Yang, Dunbiao Yao, Yang Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-07-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/15643.pdf |
Similar Items
-
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011-08-01) -
Oral Propranolol Administration in Treatment of Hemangiomas: An Update
by: Rahşan Özcan, et al.
Published: (2017-12-01) -
Oral propranolol therapy in 23 infants with infantile hemangioma
by: Jaeyoon Kim, et al.
Published: (2018-11-01) -
Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas
by: Ren L, et al.
Published: (2025-02-01) -
Oral propranolol in infantile hemangiomas: Analysis of factors that affect the outcome
by: Arun Mohanan Ainipully, et al.
Published: (2019-01-01)